EHA 2018: Inhibitor Plus Chemotherapy May Improve Outcomes in Younger Patients With FLT3-Mutant Acute Myeloid Leukemia
Chemotherapy and crenolanib can provide durable remissions without hematopoietic stem cell transplant
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.